For the first time, the FDA has recommended approving a drug derived from cannabis. It’s an important step in acknowledging it has a valid medical use, but will mean little without loosening the research restrictions that keep scientists from figuring out the other health effects of cannabis.

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website,

View all posts by Robert Zinn →